Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study
- 25 April 2019
- journal article
- research article
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 75 (4) , 275-283
Abstract
Background: Outpatient parenteral antibiotic therapy (OPAT) was not used in Belgium before 2013, except for patients with cystic fibrosis. Thus, we have performed a pilot study to evaluate clinical characteristics and outcomes of patient receiving OPAT in a Belgian setting. Methods: The study was a prospective observational single-center study of patients receiving OPAT between 1 September 2013 and 31 December, 2017. Results: We included 218 OPATs. The median age was 58 years and 71% were men. At the end of the treatment, 92% of the patients on OPAT were cured. Risk factors for treatment failure were obesity, diabetes and diabetic foot infections, longer duration of hospitalization before OPAT, and duration of OPAT >16 days. An average of 24 days of hospitalization per patient discharge was saved, which amounted to 5205 days saved during the project. During the OPAT and 30 days thereafter, 71 (32.6%) of patients were readmitted, but only 26 (12%) readmissions were directly related to OPAT. Risk factors for readmissions were diabetes and diabetic foot infections, endovascular infections, longer duration of hospitalization before OPAT, duration of OPAT >30 days, and history of hospitalizations in the year before OPAT. There were 2.3 intravenous catheter-related events per 1000 days of catheter use. Patients’ level of satisfaction was high (99.5%) Conclusions: In this pilot study, OPAT is found to be efficacious in saving hospitalization’s days, with a low rate of readmissions and complications and a high patients’ level of satisfaction. We therefore conclude that OPAT is feasible and safe Background: Outpatient parenteral antibiotic therapy (OPAT) was not used in Belgium before 2013, except for patients with cystic fibrosis. Thus, we have performed a pilot study to evaluate clinical characteristics and outcomes of patient receiving OPAT in a Belgian setting. Methods: The study was a prospective observational single-center study of patients receiving OPAT between 1 September 2013 and 31 December, 2017. Results: We included 218 OPATs. The median age was 58 years and 71% were men. At the end of the treatment, 92% of the patients on OPAT were cured. Risk factors for treatment failure were obesity, diabetes and diabetic foot infections, longer duration of hospitalization before OPAT, and duration of OPAT >16 days. An average of 24 days of hospitalization per patient discharge was saved, which amounted to 5205 days saved during the project. During the OPAT and 30 days thereafter, 71 (32.6%) of patients were readmitted, but only 26 (12%) readmissions were directly related to OPAT. Risk factors for readmissions were diabetes and diabetic foot infections, endovascular infections, longer duration of hospitalization before OPAT, duration of OPAT >30 days, and history of hospitalizations in the year before OPAT. There were 2.3 intravenous catheter-related events per 1000 days of catheter use. Patients’ level of satisfaction was high (99.5%) Conclusions: In our study, OPAT is found to be efficacious in saving hospitalization’s days, with a low rate of readmissions and complications and a high patients’ level of satisfaction. We therefore conclude that OPAT is feasible and safe.Keywords
This publication has 27 references indexed in Scilit:
- Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditisJournal of Antimicrobial Chemotherapy, 2013
- Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statementJournal of Antimicrobial Chemotherapy, 2012
- Practical Considerations in the Use of Outpatient Antimicrobial Therapy for Musculoskeletal InfectionsMayo Clinic Proceedings, 2012
- Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infectionsInternational Journal of Antimicrobial Agents, 2011
- Hospitalist to Home: Outpatient Parenteral Antimicrobial Therapy at an Academic CenterClinical Infectious Diseases, 2010
- Outpatient Parenteral Antimicrobial Therapy TodayClinical Infectious Diseases, 2010
- Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare settingEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- Establishment of an outpatient and home parenteral antimicrobial therapy service at a London teaching hospital: a case seriesJournal of Antimicrobial Chemotherapy, 2009
- Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 yearsJournal of Antimicrobial Chemotherapy, 2007
- About the Guidelines for Outpatient Parenteral Antimicrobial TherapyClinical Infectious Diseases, 2004